Compare ASST & THQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ASST | THQ |
|---|---|---|
| Founded | 2020 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Finance Companies |
| Sector | Technology | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.3B | 731.8M |
| IPO Year | 2022 | N/A |
| Metric | ASST | THQ |
|---|---|---|
| Price | $17.95 | $18.61 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $23.50 | N/A |
| AVG Volume (30 Days) | ★ 3.8M | 108.5K |
| Earning Date | 05-14-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 7.53% |
| EPS Growth | ★ 82.56 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $633,489.00 | N/A |
| Revenue This Year | $294.91 | N/A |
| Revenue Next Year | $12.16 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 128.67 | N/A |
| 52 Week Low | $0.49 | $15.14 |
| 52 Week High | $19.75 | $20.39 |
| Indicator | ASST | THQ |
|---|---|---|
| Relative Strength Index (RSI) | 60.38 | 58.42 |
| Support Level | $14.63 | $18.19 |
| Resistance Level | $17.89 | $18.86 |
| Average True Range (ATR) | 1.47 | 0.28 |
| MACD | -0.08 | 0.00 |
| Stochastic Oscillator | 57.27 | 72.59 |
Strive Inc is a structured finance company and institutional asset manager focused on disciplined capital allocation and long term value creation. The company has adopted bitcoin as its hurdle rate for capital deployment because of its fiduciary duty to maximize long-term value for stockholders, and compounding purchasing power over time. It operates in two reportable operating segments: the Asset Management segment, which provides investment advisory services and the Corporate & Other segment, which includes the company's bitcoin treasury operations. The majority of the revenue is derived from the Asset Management segment.
abrdn Healthcare Opportunities Fund is a non-diversified closed-end fund in the United States. Its investment objective is to seek current income and long-term capital appreciation through investments in U.S. and non-U.S. companies. The fund invests in equity and debt securities of public and private healthcare companies believed by the Fund's Adviser to have potential for above-average growth, and may invest in private companies and other restricted securities, including private investments in public equity and venture capital investments, provided these securities comprise 10% or less of Managed Assets.